Paper40303003
Calycosin-7-Glucoside Alleviates Atherosclerosis by Inhibiting Ox-LDL-Induced Foam Cell Formation and Inflammatory Response in THP-1-Derived Macrophages via ATF-1 Activation Through the p38/MAPK Pathway.
Chen R and 5 others. J Inflamm Res, 2025. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Calycosin-7-Glucoside Alleviates Atherosclerosis by Inhibiting Ox-LDL-Induced Foam Cell Formation and Inflammatory Response in THP-1-Derived Macrophages via ATF-1 Activation Through the p38/MAPK Pathway. Papers, record 40303003. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40303003
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Calycosin-7-Glucoside Alleviates Atherosclerosis by Inhibiting Ox-LDL-Induced Foam Cell Formation and Inflammatory Response in THP-1-Derived Macrophages via ATF-1 Activation Through the p38/MAPK Pathway.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34179023 | CREB1 and ATF1 Negatively Regulate Glutathione Biosynthesis Sensitizing Cells to Oxidative Stress. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/34179023 | PubMed |
| 2 | 15312676 | Construction and expression of intracellular anti-ATF-1 single chain Fv fragment: a modality to inhibit melanoma tumor growth and metastasis. | Methods | 2004 | https://conductscience.org/library/papers/15312676 | PubMed |
| 3 | 30486366 | Role of p38 MAPK in Atherosclerosis and Aortic Valve Sclerosis. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/30486366 | PubMed |
| 4 | 39705906 | Orally administrated acetate inhibits atherosclerosis progression through AMPK activation via GPR43 in plaque macrophages. | Atherosclerosis | 2025 | https://conductscience.org/library/papers/39705906 | PubMed |
| 5 | 22052915 | Activating transcription factor 1 directs Mhem atheroprotective macrophages through coordinated iron handling and foam cell protection. | Circ Res | 2012 | https://conductscience.org/library/papers/22052915 | PubMed |
| 6 | 10075672 | Transcriptional repression of the cystic fibrosis transmembrane conductance regulator gene, mediated by CCAAT displacement protein/cut homolog, is associated with histone deacetylation. | J Biol Chem | 1999 | https://conductscience.org/library/papers/10075672 | PubMed |
| 7 | 37679505 | MC1R signaling through the cAMP-CREB/ATF-1 and ERK-NFκB pathways accelerates G1/S transition promoting breast cancer progression. | NPJ Precis Oncol | 2023 | https://conductscience.org/library/papers/37679505 | PubMed |
| 8 | 27329155 | Reactive oxygen species (ROS) production triggered by prostaglandin D2 (PGD2) regulates lactate dehydrogenase (LDH) expression/activity in TM4 Sertoli cells. | Mol Cell Endocrinol | 2016 | https://conductscience.org/library/papers/27329155 | PubMed |
| 9 | 37121164 | Sirt4 deficiency promotes the development of atherosclerosis by activating the NF-κB/IκB/CXCL2/3 pathway. | Atherosclerosis | 2023 | https://conductscience.org/library/papers/37121164 | PubMed |
| 10 | 32141990 | miR-4286/TGF-β1/Smad3-Negative Feedback Loop Ameliorated Vascular Endothelial Cell Damage by Attenuating Apoptosis and Inflammatory Response. | J Cardiovasc Pharmacol | 2020 | https://conductscience.org/library/papers/32141990 | PubMed |
| 11 | 24051143 | 5'-AMP-activated protein kinase-activating transcription factor 1 cascade modulates human monocyte-derived macrophages to atheroprotective functions in response to heme or metformin. | Arterioscler Thromb Vasc Biol | 2013 | https://conductscience.org/library/papers/24051143 | PubMed |
| 12 | 35259610 | Flavonoids from Scutellaria barbata D. Don exert antitumor activity in colorectal cancer through inhibited autophagy and promoted apoptosis via ATF4/sestrin2 pathway. | Phytomedicine | 2022 | https://conductscience.org/library/papers/35259610 | PubMed |
| 13 | 36990011 | Analysis of the mechanism underlying diabetic wound healing acceleration by Calycosin-7-glycoside using network pharmacology and molecular docking. | Phytomedicine | 2023 | https://conductscience.org/library/papers/36990011 | PubMed |
| 14 | 37003404 | Buyang huanwu decoction inhibits diabetes-accelerated atherosclerosis via reduction of AMPK-Drp1-mitochondrial fission axis. | J Ethnopharmacol | 2023 | https://conductscience.org/library/papers/37003404 | PubMed |
| 15 | 11243876 | Signaling mechanism underlying COX-2 induction by lysophosphatidylcholine. | Biochem Biophys Res Commun | 2001 | https://conductscience.org/library/papers/11243876 | PubMed |
| 16 | 8887554 | FGF and stress regulate CREB and ATF-1 via a pathway involving p38 MAP kinase and MAPKAP kinase-2. | EMBO J | 1996 | https://conductscience.org/library/papers/8887554 | PubMed |
| 17 | 39089591 | Ganweikang extract protects hepatocytes from oxidative injury by activating Nrf2/HO-1 and MAPKs pathways. | Fitoterapia | 2024 | https://conductscience.org/library/papers/39089591 | PubMed |
| 18 | 39569201 | Mechanisms and treatment of atherosclerosis: focus on macrophages. | Front Immunol | 2024 | https://conductscience.org/library/papers/39569201 | PubMed |
| 19 | 37278811 | Cystic Fibrosis: A Review. | JAMA | 2023 | https://conductscience.org/library/papers/37278811 | PubMed |
| 20 | 35399081 | miR-589-3p promoted osteogenic differentiation of periodontal ligament stem cells through targeting ATF1. | J Orthop Surg Res | 2022 | https://conductscience.org/library/papers/35399081 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42968629 | Posttranslational Modification Cross-Talk in Vascular Cells: Molecular Mechanisms and Therapeutic Implications for Atherosclerosis. | Cell Biochem Funct | 2026 | https://conductscience.org/library/papers/42968629 | PubMed |
| 42554184 | Integrating Network Pharmacology and In Vitro Experiments to Elucidate the Antiatherosclerotic Mechanisms of Qingxin Tongmai Yin. | Mediators Inflamm | 2026 | https://conductscience.org/library/papers/42554184 | PubMed |
| 42322445 | STAT2-IRF1-ISG15-Associated Temporal Immune Reprogramming in Macrophages during Aspergillus fumigatus Infection. | Curr Microbiol | 2026 | https://conductscience.org/library/papers/42322445 | PubMed |
| 41053324 | Calycosin ameliorates inflammation and M1 macrophage polarization via Spon2 in LPS-triggered MH-S alveolar macrophages. | J Nat Med | 2025 | https://conductscience.org/library/papers/41053324 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ATF1 | 466 | PubTator's text mining | https://conductscience.org/library/genes/466 | NCBI Gene |
| CFTR | 1080 | PubTator's text mining | https://conductscience.org/library/genes/1080 | NCBI Gene |
| MAPK14 | 1432 | PubTator's text mining | https://conductscience.org/library/genes/1432 | NCBI Gene |
| NR1H2 | 7376 | PubTator's text mining | https://conductscience.org/library/genes/7376 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40303003
GET https://conductscience.org/api/papers/v1/40303003/references?page=2